In terms of prestige, Wisconsin should not be too alarmed by a recent patent office ruling that upheld the challenge to stem cell patents held by the Wisconsin Alumni Research Foundation. In this guest column, John M. Simpson of the Foundation for Taxpayer and Consumer...
Hewlett-Packard's Kristin Pugh visited Madison last week to address the subject of innovation, and advised smaller businesses to partner with a core group of clients to drive the innovative process. Hewlett-Packard, which has a 600-employee research and development lab, has acquired several smaller companies that...
Lucigen Corp. of Middleton has received a Phase II SBIR grant to complete development and commercialization of a new DNA polymerases, or enzymes, that could boost ethanol production. The follow-on grant is the second Lucigen has received as the result of bioprospecting for enzymes in...
For those who believe Wisconsin Alumni Research Foundation is in big trouble before the United States Patent and Trademark Office, remember that examiners of WARF's claims on stem cell patents have heard only from opponents, writes Inside Wisconsin columnist Tom Still. When the smoke clears...
The Milwaukee Common Council has given an extension to a local company that has been contracted to build its citywide wireless Internet network. Midwest Fiber has until June 7 to finish work in a demonstration area that was supposed to be completed in mid January....
There are some new developments in southeastern Wisconsin that involve new mass transportation to reach Chicago, but columnist James Carlini has a simple question: why not just improve what's already there? In this edition of Carlini's Comments, he makes the case for infrastructure upgades, both...
Mithridion, Inc., a Madison-based developer of drugs to slow the progression of Alzheimer's Disease, has secured a second round of venture funding as it continues to develop a drug candidate that would be used in human trials. The company already has demonstrated the efficacy of...
In the first year of his experience as a columnist, Dr. Ogan Gurel has devoted considerable newsprint to technology convergence and its impact on the healthcare industry. In this edition of MedTech Futures, he explains how compatible this trend is with the move to personalized...
Cytochroma, Inc., a company managed by former employees of Bone Care International, has settled a lawsuit filed by Genzyme Corp., the company that acquired Bone Care. The suit, which alleged the theft of intellectual property, was filed in a federal court in Wisconsin. ...
Madison's Quintessence Biosciences has taken another step in the development of its lead cancer-fighting drug. The company announced that it has met two preconditions set by the Food and Drug Administration for the drug to be tested on cancer patients, and testing could begin early...